BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9031674)

  • 1. 41-Demethylhomooligomycin B, a new immunosuppresant antibiotic from Streptomyces ostreogriseus.
    Kim HS; Han SB; Kim HM; Kim YH; Lee JJ
    J Antibiot (Tokyo); 1996 Dec; 49(12):1275-7. PubMed ID: 9031674
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligomycin F, a new immunosuppressive homologue of oligomycin A.
    Laatsch H; Kellner M; Wolf G; Lee YS; Hansske F; Konetschny-Rapp S; Pessara U; Scheuer W; Stockinger H
    J Antibiot (Tokyo); 1993 Sep; 46(9):1334-41. PubMed ID: 8226311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a new antibiotic oligomycin G produced by Streptomyces sp. WK-6150.
    Enomoto Y; Shiomi K; Matsumoto A; Takahashi Y; Iwai Y; Harder A; Kölbl H; Woodruff HB; Omura S
    J Antibiot (Tokyo); 2001 Mar; 54(3):308-13. PubMed ID: 11372788
    [No Abstract]   [Full Text] [Related]  

  • 4. Malononitrilamides inhibit T- and B-cell responsiveness.
    Kurrle R; Bartlett R; Ruuth E; Lauffer L; Schorlemmer HU
    Transplant Proc; 1996 Dec; 28(6):3053-6. PubMed ID: 8962184
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
    Wasik M; Stepień-Sopniewska B; Lagodziński Z; Górski A
    Immunopharmacology; 1990; 20(1):57-61. PubMed ID: 1699911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 44-Homooligomycin E, a new cytotoxic macrolide antibiotic from Streptomyces ostreogriseus.
    Kim HS; Band HJ; Lee SY; Yoo OJ; Yoo JC; Kim YH; Lee JJ
    Biosci Biotechnol Biochem; 1997 Feb; 61(2):378-80. PubMed ID: 9058982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell specific immunosuppression by prodigiosin isolated from Serratia marcescens.
    Han SB; Kim HM; Kim YH; Lee CW; Jang ES; Son KH; Kim SU; Kim YK
    Int J Immunopharmacol; 1998; 20(1-3):1-13. PubMed ID: 9717078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures.
    Hochlowski JE; Mullally MM; Brill GM; Whittern DN; Buko AM; Hill P; McAlpine JB
    J Antibiot (Tokyo); 1991 Dec; 44(12):1318-30. PubMed ID: 1778785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative and immunosuppressive properties of microcolin A, a marine-derived lipopeptide.
    Zhang LH; Longley RE; Koehn FE
    Life Sci; 1997; 60(10):751-62. PubMed ID: 9064480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomycins and pamamycin homologs impair motility and induce lysis of zoospores of the grapevine downy mildew pathogen, Plasmopara viticola.
    Dame ZT; Islam MT; Helmke E; von Tiedemann A; Laatsch H
    FEMS Microbiol Lett; 2016 Aug; 363(16):. PubMed ID: 27354061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity.
    Sanglier JJ; Quesniaux V; Fehr T; Hofmann H; Mahnke M; Memmert K; Schuler W; Zenke G; Gschwind L; Maurer C; Schilling W
    J Antibiot (Tokyo); 1999 May; 52(5):466-73. PubMed ID: 10480570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide-mediated tolerance of B lymphocytes for T-independent xenoantigens needs the presence of these xenoantigens.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1997; 29(1-2):1304. PubMed ID: 9123317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Streptomyces sp. 17, an organism producing oligomycin SC-iI (culture characteristics and antibiotic biological properties)].
    Bibikova MV; Grammatikova NE; Spiridonova IA; Danilenko AN; Katlinskiĭ AV
    Antibiot Khimioter; 2012; 57(7-8):3-6. PubMed ID: 23350188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cells.
    Kim HS; Raskova J; Degiannis D; Raska K
    Clin Exp Immunol; 1994 Jun; 96(3):508-12. PubMed ID: 8004821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin: in vitro profile of a new immunosuppressive macrolide.
    Sehgal SN; Bansbach CC
    Ann N Y Acad Sci; 1993 Jun; 685():58-67. PubMed ID: 8363266
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation-dependent lymphocyte apoptosis induced by methotrexate.
    Paillot R; Genestier L; Fournel S; Ferraro C; Miossec P; Revillard JP
    Transplant Proc; 1998 Aug; 30(5):2348-50. PubMed ID: 9723499
    [No Abstract]   [Full Text] [Related]  

  • 17. Ushikulides A and B, immunosuppressants produced by a strain of Streptomyces sp.
    Takahashi K; Yoshihara T; Kurosawa K
    J Antibiot (Tokyo); 2005 Jun; 58(6):420-4. PubMed ID: 16156521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice.
    Schindler JJ; Warren RP; Allen SD; Jackson MK
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2716-21. PubMed ID: 8109941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.